Table 3. Univariable and multivariable analyses on LMP10 staining of TSCC and BOTSCC in relation to DFS and OS.
DFS | OS | ||||||||||||
Univariable | Multivariable§ | Univariable | Multivariable§ | ||||||||||
HR | 95% CI | p-value | HR | 95.0% CI | p-value | HR | 95.0% CI | p-value | HR | 95.0% CI | p-value | ||
HPV-positive | |||||||||||||
Nucleus | Fraction* | 3.254 | 1.349–7.850 | .009 | 2.755 | 1.121–6.767 | .027 | 1.673 | 0.813–3.445 | .162 | 1.340 | 0.640–2.805 | .438 |
Intensity** | 2.729 | 1.019–7.310 | .046 | 2.253 | 0.827–6.135 | .112 | 2.228 | 0.956–5.194 | .063 | 1.792 | 0.754–4.261 | .187 | |
Cytoplasm | Fraction | 2.070 | 0.886–4.838 | .093 | 1.869 | 0.797–4.382 | .150 | .590 | 0.281–1.240 | .164 | .521 | 0.247–1.098 | .086 |
Intensity | 1.494 | 0.620–3.604 | .371 | 1.346 | 0.557–3.254 | .509 | .703 | 0.343–1.441 | .336 | .617 | 0.300–1.269 | .189 | |
HPV-negative | |||||||||||||
Nucleus | Fraction | 1.238 | 0.436–3.518 | .688 | 1.274 | 0.447–3.631 | .650 | .815 | 0.408–1.627 | .562 | .958 | 0.474–1.935 | .905 |
Intensity | 1.573 | 0.452–5.481 | .477 | 1.645 | 0.461–5.871 | .443 | 1.092 | 0.474–2.519 | .836 | 1.194 | 0.516–2.764 | .679 | |
Cytoplasm | Fraction | .143 | 0.033–0.631 | .010 | .154 | 0.035–0.684 | .014 | .234 | 0.090–0.610 | .003 | .281 | 0.107–0.739 | .010 |
Intensity | .204 | 0.071–0.584 | .003 | .219 | 0.073–0.653 | .006 | .405 | 0.201–0.818 | .012 | .487 | 0.236–1.004 | .051 |
Adjusted for age and tumor stage,
*absent/low vs moderate/high,
**absent vs weak/moderate/high.
Abbreviations: HR, Hazard Ratio; CI, Confidense Interval.